At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
2017/0240676 |
MOISTURE-CURABLE, SEMI-CRYSTALLINE (METH) ACRYLIC OLIGOMERS, AND
CONSTRUCTION MATERIALS INCLUDING THE SAME A composition including at least one moisture-curable, semi-crystalline (meth)acrylic oligomer represented by the formula: ##STR00001## wherein R.sub.1 is... |
2017/0240675 |
SOLUBLE MATERIAL FOR THREE-DIMENSIONAL MOLDING The soluble material for three-dimensional modeling that is used as a material of a support material that supports a three-dimensional object when... |
2017/0240674 |
CONTINUITY COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME Continuity compositions are provided as are methods of their preparation. The compositions comprise metal carboxylate salts and fatty amines and find... |
2017/0240672 |
POLYMER COMPOSITION FOR A LAYER OF A LAYER ELEMENT The present invention relates to a polymer composition, to a layer element, preferably to at least one layer element of a photovoltaic module, comprising the... |
2017/0240671 |
POLYMER COMPOSITION FOR A LAYER OF A LAYER ELEMENT The present invention relates to a polymer composition, to a layer element, preferably to at least one layer element of a photovoltaic module, comprising the... |
2017/0240670 |
POLYMER COMPOSITION FOR A LAYER OF A LAYER ELEMENT The present invention relates to a polymer composition, to a layer element, preferably to at least one layer element of a photovoltaic module, comprising the... |
2017/0240669 |
METHOD FOR PREPARING CONJUGATED DIENE-BASED POLYMER The present invention provides a method for preparing a conjugated diene-based polymer including preparing a mixture of a molecular weight modifier and a... |
2017/0240668 |
METHOD FOR THE CONTINUOUS PRODUCTION OF ANIONIC POLYMERS USING RADICALS The invention relates to a novel method for the continuous production of anionic polymers by radical polymerization. The polymers produced by said method have... |
2017/0240667 |
Catalyst System for Olefin Polymerization and Method for Producing Olefin
Polymer A phthalate-free catalyst component for olefin polymerization comprising titanium, magnesium, a halogen, diether, and oxalic acid diamides represented by the... |
2017/0240666 |
POLYMERIZATION OF 2,3,3,3-TETRAFLUOROPROPENE AND POLYMERS FORMED FROM
2,3,3,3-TETRAFLUOROPROPENE The present invention relates to methods of producing polymerized 2,3,3,3-tetrafluoropropene (poly-1234yf) using one or a combination of the techniques... |
2017/0240665 |
PROCATALYST FOR POLYMERIZATION OF OLEFINS COMPRISING A MONOESTER AND AN
AMIDOBENZOATE INTERNAL DONOR The present invention relates to a process for preparing a procatalyst for polymerization of olefins, comprising contacting a magnesium-containing support with... |
2017/0240664 |
SOLID POLYALUMINOXANE COMPOSITION, OLEFIN POLYMERIZATION CATALYST, OLEFIN
POLYMER PRODUCTION METHOD AND SOLID... An object of the invention is to provide a solid polyaluminoxane composition suitably used as a cocatalyst and a catalyst carrier in combination with an olefin... |
2017/0240663 |
METAL COMPLEX COMPRISING AMIDINE AND SUBSTITUTED CYCLOPENTADIENYL LIGANDS A metal complex of the formula (1) CyLMZ.sub.p(A).sub.n (1), wherein M is a group 4 metal Z is an anionic ligand, p is number of 1 to 2, preferably 2, Cy is a... |
2017/0240662 |
CATALYST COMPRISING A METALLOCENE COMPLEX AND A CO-CATALYST A process for the preparation of ethylene .alpha.-olefin copolymers by copolymerizing ethylene with .alpha.-olefins in the presence of a catalyst formed by... |
2017/0240661 |
Polymer product, method for producing the polymer and use of the polymer The present invention relates to a method for producing a cationic polyvinyl amine based copolymer. The present invention further relates to a cationic... |
2017/0240660 |
USING ORGANIC PHOTOREDOX CATALYSTS TO ACHIEVE METAL FREE PHOTOREGULATED
CONTROLLED RADICAL POLYMERIZATION Disclosed are methods for controlled radical polymerization of acrylic monomers using an organic photoredox catalyst, where the polymerization is mediated, as... |
2017/0240659 |
Multifunctional acylphosphine oxide photoinitiators The present invention relates to a series of novel multifunctional mono- and bis-acylphosphine oxides, which are useful as photoinitiators, and to photocurable... |
2017/0240658 |
SOFT SILICONE MEDICAL DEVICES The invention is related to a method for producing silicone medical devices, in particular, silicone contact lenses, having consistent mechanical properties in... |
2017/0240657 |
SOLUTION POLYMERS FORMED FROM METHYLENE MALONATE MONOMERS, POLYMERIZATION,
AND SOLUTION POLYMER PRODUCTS The present teachings show that it is possible to polymerize 1,1-disubstituted alkene compounds in a solution (for example using one or more solvents).... |
2017/0240656 |
PHOSPHORIC ACID-MODIFIED POLYMER The present invention is to provide a polymer which has a C--P bond. The present invention can provide a phosphoric acid-modified polymer having a double bond,... |
2017/0240655 |
METHOD FOR PRODUCING SIALIC-ACID-CONTAINING SUGAR CHAIN [Problem to be Solved] The importance of sugar chains having .alpha.2,3- or .alpha.2,6-linked sialic acid at their non-reducing ends is known. Industrial... |
2017/0240654 |
ESTERIFIED CELLULOSE ETHERS OF LOW ACETONE-INSOLUBLE CONTENT Esterified cellulose ethers which have i) as ester groups aliphatic monovalent acyl groups or groups of the formula --C(O)--R--COOA or a combination of... |
2017/0240653 |
ANTIBODIES TO OLANZAPINE HAPTENS AND USE THEREOF Disclosed is an antibody which binds to olanzapine, which can be used to detect olanzapine in a sample such as in a competitive immunoassay method. The... |
2017/0240652 |
ANTIBODIES AGAINST SEROTONIN, TRYPTOPHAN AND KYNURENINE METABOLITES AND
USES THEREOF The present invention provides antibodies and methods for preparing antibodies to metabolites in the serotonin, tryptophan and kynurenine pathways, such as... |
2017/0240651 |
AGR2 BLOCKING ANTIBODY AND USE THEREOF Disclosed is an AGR2 blocking monoclonal antibody, and in particular, a humanized monoclonal antibody for blocking AGR2. Also disclosed is a pharmaceutical... |
2017/0240650 |
INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS
RELATED TO PROTEIN FRAGMENTS OF... Provided are compositions comprising newly identified protein fragments of aminoacyl-tRNA synthetases, polynucleotides that encode them and complements... |
2017/0240649 |
LOX AND LOXL2 INHIBITORS AND USES THEREOF The present application relates to anti-LOX and anti-LOXL2 antibodies and their use in purification, diagnostic and therapeutic methods. Antibodies include... |
2017/0240648 |
ANTI-ERBB ANTIBODIES AND METHODS OF USE THEREOF Provided herein are compositions, methods and uses involving antibodies that bind to ErbB, a receptor tyrosine kinase, and modulate the activity of ErbB. Also... |
2017/0240647 |
METHOD OF MODULATING THE ACTIVITY OF FUNCTIONAL IMMUNE MOLECULES The invention relates to a method for controlling the activity of an immunologically functional molecule, such as an antibody, a protein, a peptide or the... |
2017/0240646 |
GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF According to the invention, gene products expressed in a tumor-associated manner and the nucleic acids coding therefor were identified. The invention relates... |
2017/0240645 |
ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same. |
2017/0240644 |
ANTI-PD-1 MONOCLONAL ANTIBODY AND OBTAINING METHOD THEREFOR The invention provides human monoclonal antibodies that specifically bind to PD-1 with high affinity. The anti-PD-1 monoclonal antibodies were screened from a... |
2017/0240643 |
INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGETING PROSTATE AND OTHER
CANCER CELLS In various embodiments various cancer specific antibodies and immunoconjugates are provided. In certain embodiments the antibodies specifically bind and are... |
2017/0240642 |
Anti-CD40 Antibodies, Uses and Methods The present invention relates to antibodies (and fragments, variants, fusions and derivatives thereof) with multivalent binding specificity for CD40, which... |
2017/0240641 |
Methods For Treating Type 1 Diabetes Using Glucagon Receptor Antagonistic
Antibodies The present disclosure relates to methods for treating type 1 diabetes (T1D) using a glucagon receptor blocking agent. More specifically, the present... |
2017/0240640 |
HUMAN MONOCLONAL ANTIBODIES AGAINST CD25 Isolated human monoclonal antibodies which bind to and inhibit human CD25, and related antibody-based compositions and molecules, are disclosed. The human... |
2017/0240639 |
ACTRII ANTAGONISTS FOR USE IN INCREASING IMMUNE ACTIVITY Disclosed herein are ActRII antagonists and methods for increasing immune responses and/or activity in patients in need thereof including, for example, cancer... |
2017/0240638 |
ENHANCING THE THERAPEUTIC ACTIVITY OF IMMUNE CHECKPOINT INHIBITOR The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases. |
2017/0240637 |
ANTIBODIES, COMPOSITIONS, AND USES The present disclosure describes anti-B7H3 antibody agents and uses relating thereto. Among other things, the present disclosure demonstrates particular... |
2017/0240636 |
METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANTIBODY
DIRECTED AGAINST CD28 Methods of treating autoimmune diseases, such as systemic lupus erythematosus using domain antibodies that specifically bind human CD28 are provided. The... |
2017/0240635 |
ANTI-PD-1 ANTIBODIES Anti-PD-1 antibodies are disclosed. Also disclosed are pharmaceutical compositions comprising such antibodies, and uses and methods using the same. |
2017/0240634 |
Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of
Disease and Injury of the CNS A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a... |
2017/0240633 |
Anti-TIM-3 Antibodies Anti-TIM-3 antibodies are disclosed, as well as pharmaceutical compositions comprising such antibodies, and uses and methods using the same, such as in the... |
2017/0240632 |
COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CACHEXIA OR
PRE-CACHEXIA The invention provides therapeutic, engineered protein/peptide compositions comprising e.g., RAGE antibodies, T-cell receptors to target a RAGE receptor... |
2017/0240631 |
ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF The invention is generally directed to methods and compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments,... |
2017/0240630 |
HUMAN ALPHA-FOLATE RECEPTOR CHIMERIC ANTIGEN RECEPTOR The invention provides compositions and methods for treating ovarian cancer. Specifically, the invention relates to administering a genetically modified T cell... |
2017/0240629 |
BISPECIFIC ANTIBODIES AND METHODS OF USE IN OPHTHALMOLOGY Herein are reported novel bispecific antibodies that specifically bind to two different antigens selected from the group consisting of human ANG2, human VEGF,... |
2017/0240628 |
Improved midkine antibody The present disclosure is directed to isolated or recombinant proteins, such as antibodies, which bind to, and inhibit or reduce the function of, midkine (MK)... |
2017/0240627 |
SINGLE-CHAIN VARIABLE FRAGMENT ANTI-CD133 ANTIBODIES AND USES THEREOF Disclosed herein are a monoclonal antibody that specifically binds to human CD133 and single-chain variable fragments thereof. Also disclosed herein is a... |
2017/0240626 |
BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES The present invention relates to bispecific, bivalent antibodies against human vascular endothelial growth factor (VEGF/VEGF-A) and against human ... |